BIBLIOGRAFIA
1. Rollins, B.J., Chemokines. Blood, 1997. 90(3): p. 909-28.
2. Tanaka, T., et al., Chemokines in tumor progression and metastasis. Cancer Sci, 2005. 96(6): p. 317-22.
3. Thelen, M., Dancing to the tune of chemokines. Nat Immunol, 2001. 2(2): p. 129-34.
4. Proudfoot, A.E., Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol, 2002. 2(2): p. 106-15.
5. Conti, I. and B.J. Rollins, CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol, 2004. 14(3): p. 149-54. 6. Gerard, C. and B.J. Rollins, Chemokines and disease. Nat
Immunol, 2001. 2(2): p. 108-15.
7. Cipollone, F., et al., Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol, 2001. 21(3): p. 327-34.
8. Barbero, S., et al., Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res, 2003. 63(8): p. 1969-74.
9. Erlich, P., Experimentelle Studien an maustumoren. Zeitschr Krebsforschung, 1907. 5: p. 59-81.
10. Mantovani, A., et al., The origin and function of tumor-associated macrophages. Immunol Today, 1992. 13(7): p. 265-70.
11. Rollins, B.J., Inflammatory chemokines in cancer growth and progression. Eur J Cancer, 2006. 42(6): p. 760-7.
12. Celotti, Patologia generale e fisiopatologia. 2002, Napoli: EdiSES s.r.l.
13. Dranoff, G., Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer, 2004. 4(1): p. 11-22.
14. Opdenakker, G. and J. Van Damme, The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines. Int J Dev Biol, 2004. 48(5-6): p. 519-27. 15. Yu, J.L. and J.W. Rak, Host microenvironment in breast cancer
development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res, 2003. 5(2): p. 83-8.
16. Reiland, J., L.T. Furcht, and J.B. McCarthy, CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate, 1999. 41(2): p. 78-88.
17. Kulbe, H., et al., The chemokine network in cancer--much more than directing cell movement. Int J Dev Biol, 2004. 48(5-6): p. 489-96.
18. Scotton, C., et al., Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br J Cancer, 2001.
85(6): p. 891-7.
19. Burger, M., et al., Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene, 2003. 22(50): p. 8093-101.
20. Bogenrieder, T. and M. Herlyn, Axis of evil: molecular mechanisms of cancer metastasis. Oncogene, 2003. 22(42): p. 6524-36.
21. Balkwill, F., Chemokine biology in cancer. Semin Immunol, 2003.
15(1): p. 49-55.
22. Sood, A.K., et al., Molecular determinants of ovarian cancer plasticity. Am J Pathol, 2001. 158(4): p. 1279-88.
23. Spira, A. and D.S. Ettinger, Multidisciplinary management of lung cancer. N Engl J Med, 2004. 350(4): p. 379-92.
24. Tyczynski, J.E., F. Bray, and D.M. Parkin, Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol, 2003. 4(1): p. 45-55.
25. C.Longhi, P.M., F.Passeretti, A.Pelosio, U.Recine, Medicina interna. seconda ed. 2000, Milano: McGraw-Hill Libri Italia srl. 26. Rollins, B.J., MCP-1,-2,-3,-4,-5, in Cytokine reference., F.S.
Oppenheim JJ, Durum S, Hirano T, Vilceck J, nicola N, Editor. 2000, Academic Press: London. p. 1145-1160.
27. Zachariae, C.O., et al., Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med, 1990. 171(6): p. 2177-82.
28. Rutledge, B.J., et al., High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol, 1995. 155(10): p. 4838-43. 29. Gunn, M.D., et al., Monocyte chemoattractant protein-1 is
sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol, 1997. 158(1): p. 376-83. 30. Fuentes, M.E., et al., Controlled recruitment of monocytes and
macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol, 1995. 155(12): p. 5769-76.
31. Gu, L., et al., Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell, 1998. 2(2): p. 275-81.
32. Boring, L., et al., Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature, 1998. 394(6696): p. 894-7.
33. Gosling, J., et al., MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest, 1999. 103(6): p. 773-8.
34. Dawson, T.C., et al., Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis, 1999. 143(1): p. 205-11.
35. Izikson, L., et al., Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med, 2000. 192(7): p. 1075-80.
36. Huang, D.R., et al., Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med, 2001.
193(6): p. 713-26.
37. Oshima, S., et al., Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation. Jpn Circ J, 2001. 65(4): p. 261-4.
38. Szalai, C., et al., Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis, 2001. 158(1): p. 233-9.
39. Rovin, B.H., L. Lu, and R. Saxena, A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun, 1999. 259(2): p. 344-8.
40. Valdes, A.M., et al., Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification. Arterioscler Thromb Vasc Biol, 2002. 22(11): p. 1924-8.
41. Bottazzi, B., et al., A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer, 1990. 45(4): p. 795-7.
42. Rollins, B.J. and M.E. Sunday, Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol, 1991. 11(6): p. 3125-31.
43. Walter, S., et al., Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int J Cancer, 1991. 49(3): p. 431-5.
44. Ueno, T., et al., Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res, 2000. 6(8): p. 3282-9. 45. Visscher, D.W., et al., Clinicopathologic analysis of macrophage
infiltrates in breast carcinoma. Pathol Res Pract, 1995. 191(11): p. 1133-9.
46. Steele, R.J., et al., A high macrophage content in human breast cancer is not associated with favourable prognostic factors. Br J Surg, 1984. 71(6): p. 456-8.
47. Leek, R.D., et al., Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res, 1996. 56(20): p. 4625-9.
48. Negus, R.P., et al., The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest, 1995. 95(5): p. 2391-6.
49. Ohta, M., et al., Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer, 2002.
102(3): p. 220-4.
50. Ohta, M., et al., Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol, 2003. 22(4): p. 773-8. 51. Youngs, S.J., et al., Chemokines induce migrational responses in
human breast carcinoma cell lines. Int J Cancer, 1997. 71(2): p. 257-66.
52. Salcedo, R., et al., Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood, 2000. 96(1): p. 34-40.
53. Goede, V., et al., Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer, 1999. 82(5): p. 765-70.
54. Mukaida, N., Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol, 2003.
284(4): p. L566-77.
55. Chen, J.J., et al., Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res, 2003. 9(2): p. 729-37.
56. Yao, P.L., et al., Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells. Am J Respir Cell Mol Biol, 2005.
32(6): p. 540-7.
57. Giard, D.J., et al., In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst, 1973. 51(5): p. 1417-23.
58. Conti I, D.C.a.R.B. Chemokine-based pathogenetic mechanisms in cancer. in Novartis Foundation Symposium. 2004.
59. Gerard, C. and B.J. Rollins, Chemokines and disease. Nat Immunol, 2001. 2(2): p. 108-15.
60. Arenberg, D.A., et al., Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother, 2000. 49(2): p. 63-70.
61. Standiford, T.J., et al., Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest, 1990. 86(6): p. 1945-53.
62. Standiford, T.J., et al., Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem, 1991. 266(15): p. 9912-8.
